Central Drugs Standard Control Organization

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India

Circulars

S.no Title Release Date Download Pdf Pdf Size
1 Indiscriminate use of painkillers (NSAIDs), antibiotics and associated risk of Chronic Kidney Disease 2026-Sep-22 1062 KB
2 Clarification on the submission of applications for grant of Permission to Import and Market New Drugs not approved anywhere in the world, wherein phase III Global Clinical Trials (GCT) are ongoing or completed with participation of Indian subjects under the New Drugs and Clinical Trials Rules, 2019 2026-Aug-10 400 KB
3 Vigilance on imported cosmetics products sold in the domestic market without valid lmport Registration certificate 2026-Jul-23 255 KB
4 Clarification regarding submission of applications under Rule 4 of the Drugs and Cosmetics (Compounding of Offences) Rules, 2025. 2026-Jul-22 67 KB
5 Inviting comments on consideration of the proposal regarding Issue of use of brand name extensions by the pharmaceutical firms 2026-Jul-06 53 KB
6 Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures 2026-Jun-24 323 KB
7 Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets 2026-Jun-24 758 KB
8 Submission of Post Approval Changes Applications of Registration Certificate and Import Licence of Human Vaccines and Anti-sera through SUGAM Portal 2026-Jun-24 477 KB
9 Constitution of Consultancy Committee of Key Stakeholders for Advice on Suo-Motu Disclosure under Section 4 of the RTI Act, 2005 in CDSCO 2026-Jun-16 134 KB
10 Submission of Compliance for lmported/manufactured Hair Color Cosmetics Products as per Cosmetics Rules, 2020 and applicable BIS Standards 2026-Jun-11 350 KB